The Australian Parkinson's Mission, an innovative 5 year research program, combines clinical trials and biomarker technologies with breakthrough genomics for people living with Parkinson's.
We hope to identify and validate a precision medicine framework for treating and preventing Parkinson's disease.
The Australian Parkinson's Mission (APM) is an innovative research program combining clinical trials with genomics research for people with Parkinson’s.
The APM was conceived as an Australian-led international collaboration between the Garvan Institute of Medical Research, Shake It Up Australia Foundation, the University of Sydney, the Cure Parkinson’s Trust (UK), The Michael J. Fox Foundation (USA) and Parkinson’s Australia.
In 2019 the APM received $30 million in Federal funding from the Medical Research Future Fund (MRFF) to slow and stop the progression of Parkinson’s disease.